IP Library › Assignment 036260/0570
Patent Assignment
Reel/Frame 036260/0570

Assignment of Assignor's Interest

Recorded: 2015-08-05 Pages: 15
Assignor
Assignee
ALLERGAN, INC.
2525 DUPONT DRIVE, IRVINE, CALIFORNIA, 92612
Covered Properties (14)
Use of neurotoxin therapy for treatment of urologic and related disorders
Patent: 6,365,164 →
Application: 09/463,040 →
Use of Neurotoxin Therapy for Treatment of Urologic and Related Disorders
Patent: 6,667,041 →
Application: 09/978,982 →
Publication: US 2002/0025327
Use of Neurotoxin Therapy for Treatment of Urological-Neurological Disorders Associated with Prostate Cancer
Patent: 7,470,431 →
Application: 10/655,889 →
Publication: US 2004/0180065
Use of Botulinum Toxin Therapy for Urinary Incontinence and Related Disorders
Patent: 7,001,602 →
Application: 10/685,995 →
Publication: US 2004/0126380
Use of Botulinum Toxin Therapy for Prostatic Hyperplasia and Related Disorders
Patent: 7,153,514 →
Application: 10/745,332 →
Publication: US 2004/0259788
Use of Neurotoxin Therapy for Treatment of Urologic and Related Disorders Related to Neurogenic Bladder Dysfunction
Patent: 7,449,192 →
Application: 10/778,924 →
Publication: US 2005/0048084
Use of Neurotoxin Therapy for Treatment of Urologic and Related Disorders Related to Lowering Elevated Bladder Pressure
Patent: 7,455,845 →
Application: 10/778,948 →
Publication: US 2005/0049175
Use of botulinum toxin therapy for treatment of urological neurological conditions
Patent: 9,066,943 →
Application: 10/981,015 →
Publication: US 2005/0112147
Use of Botulinum Toxin Therapy for Treatment of Recalcitrant Voiding Dysfunction
Patent: 7,429,387 →
Application: 11/077,895 →
Publication: US 2005/0159337
Use of Neurotoxin Therapy for Treatment of Urologic and Related Disorders
Patent: 8,062,643 →
Application: 11/925,938 →
Publication: US 2008/0177248
Use of Neurotoxin Therapy for Treatment of Urologic and Related Disorders
Patent: 7,968,104 →
Application: 12/133,198 →
Publication: US 2009/0004312
Use of Botulinum Toxin Therapy for Treatment of Recalcitrant Voiding Dysfunction
Patent: 8,057,807 →
Application: 12/243,659 →
Publication: US 2009/0028974
Use of neurotoxin therapy for treatment of urologic and related disorders
Patent: 8,840,905 →
Application: 12/268,993 →
Publication: US 2009/0068227
Use of Botulinum Toxin Therapy for Treatment of Urological Neurological Conditions
Application: 14/754,199 →
Publication: US 2015/0374805